The AstraZeneca PLC ADR AZN slid 1.14% to $69.95 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA rising 0.08% to ...

Companies like AstraZeneca, Daiichi Sankyo, Pfizer and Merck are learning from previous setbacks in the ADC space to improve ...

Under terms of the deal, CSPC will receive $110 million upfront, with potential milestone payments reaching up to $5.22 ...

The collaboration will focus on identifying pre-clinical candidates for high-priority targets, including a small molecule ...

Panchal is set to transition to a global role within the AstraZeneca Group, based in Gaithersburg, Maryland, US. The board acknowledged his resignation and placed on record its appreciation for his ...

SALT LAKE CITY — The pharmaceutical drug company AstraZeneca filed a lawsuit against ... The Utah Attorney General's Office declined to comment on the lawsuit. State Insurance Commissioner ...

Data presented at ASCO show that swapping in the oral drug camizestrant for an older therapy helped sustain the benefit of initial treatment, potentially opening a novel step in patient care.

JPMorgan Chase Bank has signed an agreement to buy AstraZeneca's south campus in a deal expected to close next month, giving the bank two buildings and 357,000 square feet of additional office ...

And with that, I will now hand you over to Andy Barnett, Head of Investor Relations. A warm welcome to AstraZeneca's first ... And from what we know, Custom Office and Public Security Bureau ...

AstraZeneca was advised by a Covington team led by London corporate partners Daniel Pavin and Gregor Frizzell. Over recent years, AstraZeneca has called on a range of firms to advise the company ...

On the Q4 earnings call with analysts, AstraZeneca's CEO told them: We've received a notification from the Shenzhen City Customs Office regarding ... The Pharma's Head of International also ...

AstraZeneca continued to see strong growth in 2024 on the back of a series of positive trials, as well as a solid pipeline of products. Pharmaceutical giant AstraZeneca announced its fourth ...